PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 67 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,570,354 | -25.0% | 154,098 | +3.4% | 0.02% | -39.4% |
| Q1 2023 | $3,426,816 | +1178.7% | 148,992 | +368.3% | 0.03% | +1550.0% |
| Q3 2022 | $268,000 | -29.5% | 31,814 | -33.8% | 0.00% | -50.0% |
| Q2 2022 | $380,000 | +16.9% | 48,032 | +250.6% | 0.00% | +33.3% |
| Q1 2022 | $325,000 | +45.1% | 13,700 | +174.0% | 0.00% | +50.0% |
| Q2 2021 | $224,000 | -81.8% | 5,000 | -95.1% | 0.00% | -95.5% |
| Q2 2019 | $1,233,000 | +309.6% | 101,800 | +324.2% | 0.04% | +340.0% |
| Q1 2019 | $301,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |